<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:02:17Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18983" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18983</identifier><datestamp>2026-10-18T21:03:43Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Benign Over Kisti Olan Asemptomatik Premenopozal Hastalarda Anksiyete Skorlaması</dc:title><dc:creator>MÜDERRİS, İptisam İpek</dc:creator><dc:creator>ULUĞ, Paşa</dc:creator><dc:creator>KARACA, Hicran SÖNMEZER</dc:creator><dc:creator>Ozgun, Mahmut</dc:creator><dc:subject>Kadın Hastalıkları ve Doğum</dc:subject><dc:subject>Patoloji</dc:subject><dc:subject>Psikoloji</dc:subject><dc:description>Aim: The aim of this study was to investigate the effect of oral contraceptive usage and follow-up management on the anxiety levels of asymptomatic premenopausal patients with benign ovarian cyst. Methods: Ninety asymptomatic premenopausal women were admitted to this prospective study. All of the women (21-39 years) underwent gynecological examination and transvaginal ultrasound examination. The patients with benign ovarian cyst were followed up in 3 months and divided into 2 groups. Although Group 1 was begun with oral contraceptive containing with ethinyl estradiol plus drospirenone, Group 2 was followed up without any medical treatment. Group 3 was the healthy control group without any ovarian cyst. Anxiety levels were measured by State Trait Inventory (STAI) when the patient firstly learned having cyst and after 3 months. Results: The demographic characteristics of the groups were similar. Cyst diameter and CA-125 levels were comparable between the group 1 and 2. Anxiety scores were statistically significant higher in follow-up group with ovarian cyst. Anxiety scores were lower in the oral contraceptive administered group than follow-up group. However, all of the groups that learned having benign ovarian cyst had increased anxiety scores comparing with healthy control. Conclusion: Having benign ovarian cyst without any malignancy suspicion was associated with increasing anxiety in women. Although oral contraceptive usage was not superior than following-up management for the benign ovarian cyst treatment, oral contraceptive administration might decrease patient s anxiety.</dc:description><dc:date>2015</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/18983</dc:identifier><dc:identifier>1300-2694</dc:identifier><dc:language>tr</dc:language><dc:relation>Van Tıp Dergisi</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18983</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>